Fate Therapeutics (FATE) stock Forecast for 2021 – 2025

Fate Therapeutics (FATE) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (10:40)

Sector: Healthcare

The share price of Fate Therapeutics, Inc. (FATE) now

What analysts predict: $65.33

52-week high/low: $66.56 / $17.1

50/200 Day Moving Average: $21.84 / $28.46

This figure corresponds to the average price over the previous 50/200 days. For Fate Therapeutics stocks, the 50-day moving average is the resistance level today.

For Fate Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Fate Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fate Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Fate Therapeutics share be worth in 2022 - 2026?

When should I take profit in Fate Therapeutics stock? When should I record a loss on Fate Therapeutics stock? What are analysts' forecasts for Fate Therapeutics stock? What is the future of Fate Therapeutics stock? We forecast Fate Therapeutics stock performance using neural networks based on historical data on Fate Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Fate Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Fate Therapeutics shares. This happens once a day.




Historical and forecast chart of Fate Therapeutics stock

The chart below shows the historical price of Fate Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Fate Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Fate Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 20.55 19.94 20.76 4.12
Nov 30 20.48 20.20 20.88 3.37
Dec 01 20.31 19.76 20.66 4.52
Dec 02 20.16 19.80 20.58 3.95
Dec 03 20.81 20.31 21.47 5.74
Dec 04 21.20 20.76 21.62 4.12
Dec 05 20.98 20.51 21.58 5.20
Dec 06 21.11 20.92 21.52 2.91
Dec 07 21.89 21.35 22.29 4.39
Dec 08 21.57 20.95 21.74 3.79
Dec 09 21.32 20.81 21.77 4.63
Dec 10 20.91 20.53 21.55 4.97
Dec 11 21.38 20.92 21.90 4.70
Dec 12 21.94 21.65 22.54 4.13
Dec 13 22.12 21.56 22.53 4.47
Dec 14 22.50 21.80 22.97 5.37
Dec 15 22.56 21.93 23.23 5.92
Dec 16 23.43 22.79 24.09 5.67
Dec 17 23.58 23.19 24.27 4.64
Dec 18 23.76 23.46 24.21 3.20
Dec 19 23.31 22.63 23.87 5.48
Dec 20 22.43 22.25 22.88 2.86
Dec 21 22.62 21.96 22.85 4.04
Dec 22 22.87 22.14 23.59 6.57
Dec 23 23.17 22.57 23.45 3.90
Dec 24 22.86 22.36 23.48 4.99
Dec 25 22.28 21.98 22.53 2.51
Dec 26 22.37 21.75 22.56 3.70
Dec 27 21.98 21.57 22.49 4.28
Dec 28 21.60 21.37 22.10 3.40

Fate Therapeutics Daily Price Targets


Fate Therapeutics Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $20.55.
Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.960%.
Pessimistic target level: 19.94
Optimistic target level: 20.76

Fate Therapeutics Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $20.48.
Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.256%.
Pessimistic target level: 20.20
Optimistic target level: 20.88

Fate Therapeutics Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $20.31.
Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 4.327%.
Pessimistic target level: 19.76
Optimistic target level: 20.66

Fate Therapeutics Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $20.16.
Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.801%.
Pessimistic target level: 19.80
Optimistic target level: 20.58

Fate Therapeutics Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $20.81.
Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 5.429%.
Pessimistic target level: 20.31
Optimistic target level: 21.47

Fate Therapeutics Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $21.20.
Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.961%.
Pessimistic target level: 20.76
Optimistic target level: 21.62

FATE (FATE) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 21.98 21.18 22.85 7.27

Fate Therapeutics forecast for this year


Fate Therapeutics Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $21.9842. Pessimistic: $21.18. Optimistic: $22.85



Fate Therapeutics (FATE) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 23.89 21.82 25.43 14.21
Feb 24.93 23.85 27.41 12.99
Mar 22.70 21.55 23.74 9.23
Apr 19.74 18.61 21.62 13.93
May 21.73 20.97 22.89 8.37
Jun 23.56 22.14 25.86 14.41
Jul 23.09 21.12 24.81 14.86
Aug 21.57 19.82 22.63 12.41
Sep 24.60 22.32 26.25 14.95
Oct 23.53 21.22 24.68 14.01
Nov 24.85 22.69 27.25 16.72
Dec 23.84 21.70 24.70 12.16

Fate Therapeutics (FATE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 24.67 22.39 25.47 12.07
Feb 26.26 24.49 28.54 14.17
Mar 25.89 24.73 27.02 8.45
Apr 25.20 23.69 26.16 9.44
May 27.96 26.78 30.42 11.96
Jun 26.55 24.24 29.30 17.25
Jul 25.91 23.59 26.86 12.16
Aug 24.39 23.64 25.31 6.61
Sep 26.03 25.01 28.03 10.79
Oct 24.86 23.02 27.54 16.43
Nov 24.90 22.98 27.20 15.51
Dec 23.78 22.28 24.88 10.44

Fate Therapeutics (FATE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 24.88 22.93 26.48 13.42
Feb 26.41 24.12 27.78 13.18
Mar 27.56 25.25 30.30 16.68
Apr 25.63 24.16 26.46 8.68
May 25.56 23.63 27.53 14.17
Jun 24.41 21.99 26.71 17.66
Jul 24.18 22.58 25.77 12.35
Aug 25.50 24.17 27.60 12.41
Sep 25.71 24.56 27.58 10.96
Oct 24.05 22.13 25.20 12.16
Nov 25.06 23.91 25.80 7.34
Dec 23.73 21.70 24.79 12.46

Fate Therapeutics (FATE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 23.93 22.29 25.37 12.15
Feb 23.96 21.88 25.37 13.75
Mar 20.68 19.92 21.49 7.27
Apr 20.27 19.19 22.46 14.53
May 20.21 18.15 22.11 17.92
Jun 19.56 17.56 21.29 17.50
Jul 18.69 16.93 19.34 12.44
Aug 20.52 19.54 21.35 8.48
Sep 22.24 19.87 23.49 15.38
Oct 24.14 23.06 25.05 7.96
Nov 24.31 21.96 25.36 13.42
Dec 26.83 24.42 28.44 14.13

Fate Therapeutics information and performance

Fate Therapeutics, Inc. provides biopharmaceutical services. The company researches and develops therapies for the restoration and regeneration of body tissues using stem cells. The company operates in the USA.

Official website of the company

Fate Therapeutics Address

3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, US

Market Capitalization: 1 930 776 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -302 227 008 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.438

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.053
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 22.26

Enterprise Value (EV) /Revenue

EV To EBITDA: -5.17

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 97170000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.